Silibinin Improves Blood Vessel Function in Diabetic Mice
Author Information
Author(s): Li Volti Giovanni, Salomone Salvatore, Sorrenti Valeria, Mangiameli Andrea, Urso Vincenzo, Siarkos Ilias, Galvano Fabio, Salamone Federico
Primary Institution: Department of Drug Sciences, University of Catania, Catania, Italy
Hypothesis
Does silibinin reduce ADMA levels and improve endothelial dysfunction in obese diabetic mice?
Conclusion
Silibinin significantly improves endothelial dysfunction in diabetic mice by lowering ADMA levels.
Supporting Evidence
- Silibinin reduced plasma ADMA levels in db/db mice.
- Endothelium-dependent vasodilatation to acetylcholine was improved in silibinin-treated mice.
- ADMA levels were positively correlated between plasma and aorta.
Takeaway
Silibinin, a natural compound, helps make blood vessels work better in diabetic mice by lowering a harmful substance in their blood.
Methodology
Eighteen db/db mice were treated with silibinin or vehicle for four weeks, and various biochemical analyses were performed.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
Eight-week-old male db/db and db/m mice.
Statistical Information
P-Value
p<0.05
Confidence Interval
(95% confidence limits are given in parenthesis)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website